| Schedule of revenues and net income from operations |
| Schedule of revenues and net income from operations | |
| | |
| |
| | |
September 30, 2025 | | |
December 31, 2024 | |
| Asset: | |
| | | |
| | |
| Healthcare | |
$ | 25,975,901 | | |
$ | 21,298,866 | |
| Real Estate | |
| 547,705 | | |
| 576,478 | |
| Corporate, administration and other | |
| 1,085,910 | | |
| 2,050,335 | |
| Consolidated assets | |
$ | 27,609,516 | | |
$ | 23,925,679 | |
| | |
Three Months Ended September 30, | |
| | |
2025 | | |
2024 | |
| Revenues: | |
| | | |
| | |
| Healthcare | |
$ | 3,058,740 | | |
$ | 1,355,641 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated revenues | |
$ | 3,058,740 | | |
$ | 1,355,641 | |
| | |
| | | |
| | |
| Cost of sales: | |
| | | |
| | |
| Healthcare | |
$ | 1,149,161 | | |
$ | 1,000,601 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated cost of sales | |
$ | 1,149,161 | | |
$ | 1,000,601 | |
| | |
| | | |
| | |
| Operating Expenses: | |
| | | |
| | |
| Healthcare | |
| | | |
| | |
| Depreciation expense | |
$ | 762 | | |
$ | 3,365 | |
| Selling, general and administrative | |
| 265,289 | | |
| 213,478 | |
| Total Healthcare | |
| 266,051 | | |
| 216,843 | |
| Real Estate | |
| 25 | | |
| 4,000 | |
| Corporate, administration and other expenses (a) | |
| 1,000,224 | | |
| 719,357 | |
| Consolidated operating expenses | |
$ | 1,266,300 | | |
$ | 940,200 | |
| | |
| | | |
| | |
| Income (loss) from operations from subsidiaries: | |
| | | |
| | |
| Healthcare | |
$ | 1,643,528 | | |
$ | 138,197 | |
| Real Estate | |
| (25 | ) | |
| (4,000 | ) |
| Income from operations from subsidiaries | |
| 1,643,503 | | |
| 134,197 | |
| Loss from operations from Cardiff Lexington | |
| (1,000,224 | ) | |
| (719,357 | ) |
| Total income (loss) from operations | |
$ | 643,279 | | |
$ | (585,160 | ) |
| | |
| | | |
| | |
| Income (loss) before taxes | |
| | | |
| | |
| Healthcare | |
$ | 1,643,528 | | |
$ | 138,197 | |
| Real Estate | |
| (25 | ) | |
| (4,000 | ) |
| Corporate, administration and other non-operating expenses (b) | |
| (2,787,802 | ) | |
| (2,112,165 | ) |
| Consolidated loss from continuing operations | |
$ | (1,144,299 | ) | |
$ | (1,977,968 | ) |
| | |
Nine Months Ended September 30, | |
| | |
2025 | | |
2024 | |
| Revenues: | |
| | | |
| | |
| Healthcare | |
$ | 8,763,314 | | |
$ | 5,149,416 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated revenues | |
$ | 8,763,314 | | |
$ | 5,149,416 | |
| | |
| | | |
| | |
| Cost of sales: | |
| | | |
| | |
| Healthcare | |
$ | 3,317,943 | | |
$ | 2,741,765 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated cost of sales | |
$ | 3,317,943 | | |
$ | 2,741,765 | |
| | |
| | | |
| | |
| Operating Expenses: | |
| | | |
| | |
| Healthcare | |
| | | |
| | |
| Depreciation expense | |
$ | 4,890 | | |
$ | 10,096 | |
| Loss on disposal of fixed assets | |
| 12,593 | | |
| – | |
| Selling, general and administrative | |
| 852,978 | | |
| 658,456 | |
| Total Healthcare | |
| 870,461 | | |
| 668,552 | |
| Real Estate | |
| 29,143 | | |
| 8,836 | |
| Corporate, administration and other expenses (a) | |
| 2,748,877 | | |
| 2,255,914 | |
| Consolidated operating expenses | |
$ | 3,648,481 | | |
$ | 2,933,302 | |
| | |
| | | |
| | |
| Income (loss) from operations from subsidiaries: | |
| | | |
| | |
| Healthcare | |
$ | 4,574,910 | | |
$ | 1,739,099 | |
| Real Estate | |
| (29,143 | ) | |
| (8,836 | ) |
| Income from operations from subsidiaries | |
| 4,545,767 | | |
| 1,730,263 | |
| Loss from operations from Cardiff Lexington | |
| (2,748,877 | ) | |
| (2,255,914 | ) |
| Total income (loss) from operations | |
$ | 1,796,890 | | |
$ | (525,651 | ) |
| | |
| | | |
| | |
| Income (loss) before taxes | |
| | | |
| | |
| Healthcare | |
$ | 4,573,313 | | |
$ | 1,739,099 | |
| Real Estate | |
| (29,143 | ) | |
| (8,836 | ) |
| Corporate, administration and other non-operating expenses (b) | |
| (7,365,641 | ) | |
| (4,011,608 | ) |
| Consolidated loss from continuing operations | |
$ | (2,821,471 | ) | |
$ | (2,281,345 | ) |
| (a) |
Corporate, administration and other operating expenses includes payroll, management fees, stock compensation, legal fees, accounting fees and public company/investor relations fees. |
| |
|
| (b) |
Corporate, administration and other non-operating expenses includes corporate selling, general and administrative expenses such as noted above as well as interest, amortization of notes payable discount and gain on settlement of debt. |
|